Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy
Article Information
vol. 68 no. 2 395-408
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 28, 2018
- Accepted October 31, 2018
- Published in print January 21, 2019.
- Published online ahead of print November 13, 2018.
Article Versions
- Previous version (November 13, 2018 - 07:35).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Author Information
- Zhonglin Chai1⇑,
- Tieqiao Wu1,
- Aozhi Dai1,
- Pacific Huynh1,
- Frank Koentgen2,
- Guy Krippner3,
- Shuting Ren1,4 and
- Mark E. Cooper1
- 1Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia
- 2Ozgene Pty Ltd., Bentley, Western Australia, Australia
- 3Department of Commercialization, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
- 4Department of Pathology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Centre, Xi’an, People’s Republic of China
- Corresponding author: Zhonglin Chai, zhonglin.chai{at}monash.edu
Statistics from Altmetric.com
Article usage
In this Issue
February 2019, 68(2)
Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy
